SRRK Q1 2024 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$5B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$598,000

Operating Income

-$58M

Net Income

-$57M

EPS (Diluted)

$-0.59

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$50M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$267M

Total Liabilities

$85M

Stockholders' Equity

$183M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$598,000	-$3M	+76.5%
Operating Income	-$58M	-$41M	-44.2%
Net Income	-$57M	-$39M	-44.4%